82 FR 19083 - Importer of Controlled Substances Application: Cambridge Isotope Laboratories
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 78 (April 25, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 78 (April 25, 2017)
| Page Range | 19083-19084 | |
| FR Document | 2017-08346 |
[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)] [Notices] [Pages 19083-19084] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-08346] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Cambridge Isotope Laboratories ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before May 25, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before May 25, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement [[Page 19084]] Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/ DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers importers, and exporters of, controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on August 25, 2016, Cambridge Isotope Laboratories, 50 Frontage Road, Andover, Massachusetts 01810 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Mephedrone (4-Methyl-N- 1248 I methylcathinone). Gamma Hydroxybutyric Acid........... 2010 I Methaqualone........................ 2565 I Lysergic acid diethylamide.......... 7315 I Marihuana........................... 7360 I Tetrahydrocannabinols............... 7370 I 3,4-Methylenedioxyamphetamine....... 7400 I 3,4-Methylenedioxy-N- 7404 I ethylamphetamine. 3,4-Methylenedioxymethamphetamine... 7405 I Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Butylone............................ 7541 I Heroin.............................. 9200 I Pentobarbital....................... 2270 II Secobarbital........................ 2315 II Phencyclidine....................... 7471 II Cocaine............................. 9041 II Dihydrocodeine...................... 9120 II Ecgonine............................ 9180 II Meperidine.......................... 9230 II Dextropropoxyphene, bulk (non-dosage 9273 II forms). Fentanyl............................ 9801 II ------------------------------------------------------------------------ The company plans to import the listed controlled substances for analytical research, testing and clinical trials. Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017-08346 Filed 4-24-17; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices 19083
This action is taken under the redelegated to the Assistant In accordance with 21 CFR
authority of section 337 of the Tariff Act Administrator of the DEA Diversion 1301.33(a), this is notice that on June 1,
of 1930, as amended (19 U.S.C. 1337), Control Division (‘‘Assistant 2016, Cedarburg Pharmaceuticals Inc., A
and of §§ 201.10 and 210.8(c) of the Administrator’’) pursuant to section 7 of Division of Albany Molecular Research
Commission’s Rules of Practice and 28 CFR part 0, appendix to subpart R. Inc. (AMRI), 870 Badger Circle, Grafton,
Procedure (19 CFR 201.10, 210.8(c)). In accordance with 21 CFR Wisconsin 53024 applied to be
By order of the Commission.
1301.34(a), this is notice that on registered as a bulk manufacturer of the
December 16, 2016, Janssen Ortho LLC, following basic classes of controlled
Dated: April 18, 2017.
State Road 933 DM 0.1 Mamey Ward, substances:
Lisa R. Barton, Gurabo, Puerto Rico 00778 applied to be
Secretary to the Commission. registered as an importer of tapentadol Drug
Controlled Substance Schedule
[FR Doc. 2017–08232 Filed 4–24–17; 8:45 am] (9780), a basic class of controlled Code
BILLING CODE 7020–02–P substance listed in schedule II.
The company plans to import an Marihuana ................... 7360 I
Tetrahydrocannabinols 7370 I
intermediate form of tapentadol (9780) Lisdexamfetamine ...... 1205 II
DEPARTMENT OF JUSTICE to bulk manufacture tapentadol for 4-Anilino-N-phenethyl- 8333 II
distribution to its customers. 4-piperidine (ANPP).
Drug Enforcement Administration Dated: April 18, 2017. Remifentanil ................ 9739 II
Louis J. Milione, Fentanyl ...................... 9801 II
[Docket No. DEA–392]
Assistant Administrator.
Importer of Controlled Substances The company plans to manufacture
[FR Doc. 2017–08345 Filed 4–24–17; 8:45 am]
Application: Janssen Ortho LLC the above-listed controlled substances
BILLING CODE 4410–09–P in bulk for distribution to its customers.
ACTION: Notice of application. In reference to drug codes 7360
marihuana, the company plans to bulk
DEPARTMENT OF JUSTICE
DATES: Registered bulk manufacturers of manufacture cannabidiol as a synthetic
the affected basic class, and applicants Drug Enforcement Administration intermediate. This controlled substance
therefore, may file written comments on will be further synthesized to bulk
or objections to the issuance of the [Docket No. DEA–392] manufacture a synthetic
proposed registration in accordance tetrahydrocannabinols 7370. No other
Bulk Manufacturer of Controlled
with 21 CFR 1301.34(a) on or before activity for this drug code is authorized
Substances Application: Cedarburg
May 25, 2017. Such persons may also for this registration.
Pharmaceuticals
file a written request for a hearing on Dated: April 18, 2017.
the application pursuant to 21 CFR ACTION: Notice of application. Louis J. Milione,
1301.43 on or before May 25, 2017. Assistant Administrator.
ADDRESSES: Written comments should DATES: Registered bulk manufacturers of
[FR Doc. 2017–08343 Filed 4–24–17; 8:45 am]
be sent to: Drug Enforcement the affected basic classes, and
BILLING CODE 4410–09–P
Administration, Attention: DEA Federal applicants therefore, may file written
Register Representative/DRW, 8701 comments on or objections to the
Morrissette Drive, Springfield, Virginia issuance of the proposed registration in
DEPARTMENT OF JUSTICE
22152. All requests for hearing must be accordance with 21 CFR 1301.33(a) on
sent to: Drug Enforcement or before June 26, 2017. Drug Enforcement Administration
Administration, Attn: Administrator, ADDRESSES: Written comments should
[Docket No. DEA–392]
8701 Morrissette Drive, Springfield, be sent to: Drug Enforcement
Virginia 22152. All requests for hearing Administration, Attention: DEA Federal Importer of Controlled Substances
should also be sent to: (1) Drug Register Representative/DRW, 8701 Application: Cambridge Isotope
Enforcement Administration, Attn: Morrissette Drive, Springfield, Virginia Laboratories
Hearing Clerk/LJ, 8701 Morrissette 22152.
Drive, Springfield, Virginia 22152; and SUPPLEMENTARY INFORMATION: The ACTION: Notice of application.
(2) Drug Enforcement Administration, Attorney General has delegated his
Attn: DEA Federal Register authority under the Controlled DATES: Registered bulk manufacturers of
Representative/DRW, 8701 Morrissette Substances Act to the Administrator of the affected basic classes, and
Drive, Springfield, Virginia 22152. the Drug Enforcement Administration applicants therefore, may file written
SUPPLEMENTARY INFORMATION: The (DEA), 28 CFR 0.100(b). Authority to comments on or objections to the
Attorney General has delegated his exercise all necessary functions with issuance of the proposed registration in
authority under the Controlled respect to the promulgation and accordance with 21 CFR 1301.34(a) on
Substances Act to the Administrator of implementation of 21 CFR part 1301, or before May 25, 2017. Such persons
the Drug Enforcement Administration incident to the registration of may also file a written request for a
(DEA), 28 CFR 0.100(b). Authority to manufacturers, distributors, dispensers, hearing on the application pursuant to
exercise all necessary functions with importers, and exporters of controlled 21 CFR 1301.43 on or before May 25,
asabaliauskas on DSK3SPTVN1PROD with NOTICES
respect to the promulgation and substances (other than final orders in 2017.
implementation of 21 CFR part 1301, connection with suspension, denial, or ADDRESSES: Written comments should
incident to the registration of revocation of registration) has been be sent to: Drug Enforcement
manufacturers, distributors, dispensers, redelegated to the Assistant Administration, Attention: DEA Federal
importers, and exporters of controlled Administrator of the DEA Diversion Register Representative/DRW, 8701
substances (other than final orders in Control Division (‘‘Assistant Morrissette Drive, Springfield, Virginia
connection with suspension, denial, or Administrator’’) pursuant to section 7 of 22152. All requests for hearing must be
revocation of registration) has been 28 CFR part 0, appendix to subpart R. sent to: Drug Enforcement
VerDate Sep<11>2014 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\25APN1.SGM 25APN1](https://thefederalregister.org/doc/82_FR_19161/page/1.svg)
![19084 Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices
Administration, Attn: Administrator, authority under the Controlled redelegated to the Assistant
8701 Morrissette Drive, Springfield, Substances Act to the Administrator of Administrator of the DEA Diversion
Virginia 22152. All requests for hearing the Drug Enforcement Administration Control Division (‘‘Assistant
should also be sent to: (1) Drug (DEA), 28 CFR 0.100(b). Authority to Administrator’’) pursuant to section 7 of
Enforcement Administration, Attn: exercise all necessary functions with 28 CFR part 0, appendix to subpart R.
Hearing Clerk/LJ, 8701 Morrissette respect to the promulgation and In accordance with 21 CFR
Drive, Springfield, Virginia 22152; and implementation of 21 CFR part 1301, 1301.34(a), this is notice that on August
(2) Drug Enforcement Administration, incident to the registration of 25, 2016, Cambridge Isotope
Attn: DEA Federal Register manufacturers, distributors, dispensers Laboratories, 50 Frontage Road,
Representative/DRW, 8701 Morrissette importers, and exporters of, controlled Andover, Massachusetts 01810 applied
Drive, Springfield, Virginia 22152. substances (other than final orders in to be registered as an importer of the
SUPPLEMENTARY INFORMATION: The connection with suspension, denial, or following basic classes of controlled
Attorney General has delegated his revocation of registration) has been substances:
Controlled substance Drug code Schedule
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................. 1248 I
Gamma Hydroxybutyric Acid ......................................................................................................................................... 2010 I
Methaqualone ................................................................................................................................................................ 2565 I
Lysergic acid diethylamide ............................................................................................................................................ 7315 I
Marihuana ...................................................................................................................................................................... 7360 I
Tetrahydrocannabinols .................................................................................................................................................. 7370 I
3,4-Methylenedioxyamphetamine .................................................................................................................................. 7400 I
3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine .......................................................................................................................... 7405 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................... 7540 I
Butylone ......................................................................................................................................................................... 7541 I
Heroin ............................................................................................................................................................................ 9200 I
Pentobarbital .................................................................................................................................................................. 2270 II
Secobarbital ................................................................................................................................................................... 2315 II
Phencyclidine ................................................................................................................................................................. 7471 II
Cocaine .......................................................................................................................................................................... 9041 II
Dihydrocodeine .............................................................................................................................................................. 9120 II
Ecgonine ........................................................................................................................................................................ 9180 II
Meperidine ..................................................................................................................................................................... 9230 II
Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................ 9273 II
Fentanyl ......................................................................................................................................................................... 9801 II
The company plans to import the DATES: Registered bulk manufacturers of implementation of 21 CFR part 1301,
listed controlled substances for the affected basic classes, and incident to the registration of
analytical research, testing and clinical applicants therefore, may file written manufacturers, distributors, dispensers,
trials. comments on or objections to the importers, and exporters of controlled
Dated: April 18, 2017. issuance of the proposed registration in substances (other than final orders in
Louis J. Milione, accordance with 21 CFR 1301.33(a) on connection with suspension, denial, or
Assistant Administrator.
or before June 26, 2017. revocation of registration) has been
[FR Doc. 2017–08346 Filed 4–24–17; 8:45 am] ADDRESSES: Written comments should redelegated to the Assistant
BILLING CODE 4410–09–P
be sent to: Drug Enforcement Administrator of the DEA Diversion
Administration, Attention: DEA Federal Control Division (‘‘Assistant
Register Representative/DRW, 8701 Administrator’’) pursuant to section 7 of
DEPARTMENT OF JUSTICE Morrissette Drive, Springfield, Virginia 28 CFR part 0, appendix to subpart R.
22152.
Drug Enforcement Administration In accordance with 21 CFR
SUPPLEMENTARY INFORMATION: The 1301.33(a), this is notice that on
[Docket No. DEA–392] Attorney General has delegated his November 22, 2016, Siegfried USA,
authority under the Controlled LLC, 33 Industrial Park Road,
Bulk Manufacturer of Controlled Substances Act to the Administrator of Pennsville, New Jersey 08070 applied to
Substances Application: Siegfried the Drug Enforcement Administration be registered as a bulk manufacturer of
USA, LLC (DEA), 28 CFR 0.100(b). Authority to the following basic classes of controlled
exercise all necessary functions with substances:
ACTION: Notice of application.
respect to the promulgation and
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Controlled substance Drug code Schedule
Gamma Hydroxybutyric Acid ......................................................................................................................................... 2010 I
Dihydromorphine ............................................................................................................................................................ 9145 I
Hydromorphinol .............................................................................................................................................................. 9301 I
Methylphenidate ............................................................................................................................................................. 1724 II
Amobarbital .................................................................................................................................................................... 2125 II
Pentobarbital .................................................................................................................................................................. 2270 II
Secobarbital ................................................................................................................................................................... 2315 II
VerDate Sep<11>2014 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\25APN1.SGM 25APN1](https://thefederalregister.org/doc/82_FR_19161/page/2.svg)
Document Created: 2017-04-25 02:18:33
Document Modified: 2017-04-25 02:18:33
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before May 25, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before May 25, 2017. | |
| FR Citation | 82 FR 19083 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR